Trending...
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- Consortium Media Appoints Jennifer Curtis-Neves as President of Consortium Media
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between May 28, 2021 and May 24, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before August 5, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Verrica suffered from manufacturing problems at its contract manufacturer's facility during bulk production of its lead product candidate, VP-102. These deficiencies had not been successfully remediated when the Company resubmitted its NDA for VP-102 to the FDA. This failure was likely to impact the chances of regulatory approval for the Company's product candidate. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Verrica, investors suffered damages.
More on The Californer
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Investors who purchased the Company's securities between May 28, 2021 and May 24, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before August 5, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- Tuesday Night Comics at North Coast Rep
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Author Explodes Damning Myths about Hunger in America
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Verrica suffered from manufacturing problems at its contract manufacturer's facility during bulk production of its lead product candidate, VP-102. These deficiencies had not been successfully remediated when the Company resubmitted its NDA for VP-102 to the FDA. This failure was likely to impact the chances of regulatory approval for the Company's product candidate. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Verrica, investors suffered damages.
More on The Californer
- California: Happy Birthday, National Guard!
- Umbrella by J French Premieres Live at 8586 in the Beverly Center on December 22
- Affordable Luxury Bracelets to Gift This Christmas: Timeless Style with 40% Holiday Savings
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Filed Under: Business
0 Comments
Latest on The Californer
- No Tipping Car Wash in Northridge CA
- California state parks are for everyone, while Trump turns national parks into his vanity project
- California: Trump's AI executive order advances corruption, not innovation
- Governor Newsom deploys California resources to Washington to support flood response efforts
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Relief Alliance Skid Row Outreach Brings Celebrities and Volunteers Together for Community Impact
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Car Wash in Northridge Under $10
- Only 3 Spots Left for Rise Within: Wellness Retreat Los Cabos – January 2026
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- bisco industries New Authorized Line: SKF Aerospace
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Baby Boomers: The Perfect Cash Buyers in Today's Market
- Stray Theories Unveils Falter, an Atmospheric Passage Through the Spaces Between Doubt and Hope
- Holiday Decorations Most Likely to Cause Injuries
- Daniel S. Romero, CFP® Earns Renowned Certification for Fiduciary Excellence
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- California: Coho salmon are making a comeback in the Russian River for the first time in 30 years
- DKN Hotels Acquires Residence Inn by Marriott San Diego Sorrento Mesa/Sorrento Valley
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm